Paul Tudor Jones Talaris Therapeutics, Inc. Transaction History

Tudor Investment Corp Et Al

  • $26.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$4.51 - $9.85 $56,361 - $123,095
-12,497 Reduced 22.73%
42,491 $192,000
Q1 2022

May 16, 2022
BUY
$6.89 - $16.56 $3,941 - $9,472
572 Added 1.05%
54,988 $541,000
Q4 2021

Feb 14, 2022
SELL
$12.18 - $17.0 $528,721 - $737,953
-43,409 Reduced 44.37%
54,416 $832,000
Q3 2021

Nov 15, 2021
SELL
$11.61 - $15.99 $13,049 - $17,972
-1,124 Reduced 1.14%
97,825 $1.33 Million
Q2 2021

Aug 16, 2021
BUY
$12.25 - $18.61 $1.21 Million - $1.84 Million
98,949 New
98,949 $1.45 Million

Others Institutions Holding TALS

# of Institutions
3
Shares Held
75.7K
Call Options Held
0
Put Options Held
0
View Full List

About Talaris Therapeutics, Inc.

TALS Quotes by TradingView
  • Ticker TALS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,995,900
  • Market Cap $109M
  • Description
  • Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...
More about TALS
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email